Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.6.3 was added to the history and Revision: v3.6.2 was removed, representing a small software version update to the page’s underlying system.SummaryDifference0.0%

- Check16 days agoChange DetectedA new revision entry (v3.6.2) was added to the page history, replacing the previous v3.6.0 entry. This indicates a minor update to the page's revision notes.SummaryDifference0.0%

- Check31 days agoChange DetectedThe study history now indicates enrollment is closed, and the record version has been updated to v3.6.0 (removing the prior v3.5.5).SummaryDifference0.3%

- Check38 days agoChange DetectedThe footer's revision tag was updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page footer revision label has been updated from v3.5.3 to v3.5.4, indicating a minor version update.SummaryDifference0.0%

- Check73 days agoChange DetectedA new revision entry, v3.5.3, was added to the study's history, replacing the previous v3.5.2. This updates the record history to reflect an additional iteration of the record.SummaryDifference0.0%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.